share_log

Trevi Therapeutics Shares Are Trading Higher After the Company Announced Positive Outcomes for the Treatment of Patients From Its Chronic Cough Phase 2b CORAL Trial.

Benzinga ·  Dec 12 21:14
Trevi Therapeutics Shares Are Trading Higher After the Company Announced Positive Outcomes for the Treatment of Patients From Its Chronic Cough Phase 2b CORAL Trial.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment